$EXPO
EXPONENT INC

2017 Q2 Form 10-Q Financial Statement

#000114420417040607 Filed on August 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q2
Revenue $87.84M
YoY Change 5.63%
Cost Of Revenue $3.700M
YoY Change -11.9%
Gross Profit $84.10M
YoY Change 6.46%
Gross Profit Margin 95.74%
Selling, General & Admin $56.50M
YoY Change 1.8%
% of Gross Profit 67.18%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.600M
YoY Change 14.29%
% of Gross Profit 1.9%
Operating Expenses $63.80M
YoY Change -4.38%
Operating Profit $20.32M
YoY Change 23.61%
Interest Expense $300.0K
YoY Change 200.0%
% of Operating Profit 1.48%
Other Income/Expense, Net $2.031M
YoY Change 56.47%
Pretax Income $22.35M
YoY Change 26.02%
Income Tax $8.557M
% Of Pretax Income 38.29%
Net Earnings $13.79M
YoY Change -10.16%
Net Earnings / Revenue 15.7%
Basic Earnings Per Share $0.26
Diluted Earnings Per Share $0.26
COMMON SHARES
Basic Shares Outstanding 52.83M
Diluted Shares Outstanding 53.94M

Balance Sheet

Concept 2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $162.0M
YoY Change 4.52%
Cash & Equivalents $90.23M
Short-Term Investments $71.80M
Other Short-Term Assets $9.300M
YoY Change -20.51%
Inventory
Prepaid Expenses
Receivables $107.4M
Other Receivables $0.00
Total Short-Term Assets $278.7M
YoY Change 6.5%
LONG-TERM ASSETS
Property, Plant & Equipment $35.90M
YoY Change 25.96%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.50M
YoY Change 9.91%
Total Long-Term Assets $131.0M
YoY Change 13.22%
TOTAL ASSETS
Total Short-Term Assets $278.7M
Total Long-Term Assets $131.0M
Total Assets $409.7M
YoY Change 8.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.60M
YoY Change 29.27%
Accrued Expenses $50.90M
YoY Change 27.25%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $68.10M
YoY Change 24.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $52.20M
YoY Change 4.19%
Total Long-Term Liabilities $52.20M
YoY Change 4.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $68.10M
Total Long-Term Liabilities $52.20M
Total Liabilities $120.3M
YoY Change 14.68%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares 7.060M shares
Shareholders Equity $289.4M
YoY Change
Total Liabilities & Shareholders Equity $409.7M
YoY Change 8.56%

Cashflow Statement

Concept 2017 Q2
OPERATING ACTIVITIES
Net Income $13.79M
YoY Change -10.16%
Depreciation, Depletion And Amortization $1.600M
YoY Change 14.29%
Cash From Operating Activities $19.00M
YoY Change 6233.33%
INVESTING ACTIVITIES
Capital Expenditures $1.219M
YoY Change -17.69%
Acquisitions
YoY Change
Other Investing Activities -$4.000M
YoY Change -62.26%
Cash From Investing Activities -$5.200M
YoY Change -56.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -11.00M
YoY Change -28.57%
NET CHANGE
Cash From Operating Activities 19.00M
Cash From Investing Activities -5.200M
Cash From Financing Activities -11.00M
Net Change In Cash 2.800M
YoY Change -110.33%
FREE CASH FLOW
Cash From Operating Activities $19.00M
Capital Expenditures $1.219M
Free Cash Flow $17.78M
YoY Change -1605.59%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
454000 USD
CY2016Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-505000 USD
CY2017Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-32000 USD
CY2016Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 USD
CY2017Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
14213000 USD
CY2016Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9947000 USD
us-gaap Net Income Loss
NetIncomeLoss
30367000 USD
us-gaap Net Income Loss
NetIncomeLoss
25803000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
3195000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2927000 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
0 USD
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-14000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-205000 USD
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-184000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
805000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1131000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
9187000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
7929000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1217000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
424000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
20840000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4863000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3365000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5198000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
928000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1716000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9806000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-9712000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1022000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-2010000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
17191000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14545000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2526000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3382000 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
21450000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15526000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5932000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
13000000 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
24000000 USD
CY2017Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.21
CY2017Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
5374000 USD
CY2017Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
9259000 USD
CY2017Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
129692000 USD
CY2017Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
54082000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
21918000 USD
CY2016Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
128940000 USD
CY2016Q4 expo Deferred Compensation Plan Liabilities Fair Value Disclosure
DeferredCompensationPlanLiabilitiesFairValueDisclosure
53617000 USD
CY2016Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
53617000 USD
CY2017Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
162233000 USD
CY2017Q2 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0 USD
CY2017Q2 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
237000 USD
CY2017Q2 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
161996000 USD
CY2016Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
173967000 USD
CY2016Q4 expo Available For Sale Securities Gross Unrealized Gain Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedGainAccumulatedInInvestments
0 USD
CY2016Q4 expo Available For Sale Securities Gross Unrealized Loss Accumulated In Investments
AvailableForSaleSecuritiesGrossUnrealizedLossAccumulatedInInvestments
245000 USD
CY2016Q4 expo Cash Cash Equivalents And Short Term Investments Fair Value Disclosure
CashCashEquivalentsAndShortTermInvestmentsFairValueDisclosure
173722000 USD
CY2017Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearOne
32000000 USD
CY2017Q2 expo Available For Sale Securities Short Term Investments Amortized Cost Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsAmortizedCostDueInYearTwo
40000000 USD
CY2017Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
72000000 USD
CY2017Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year One
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearOne
31936000 USD
CY2017Q2 expo Available For Sale Securities Short Term Investments Estimated Fair Value Due In Year Two
AvailableForSaleSecuritiesShortTermInvestmentsEstimatedFairValueDueInYearTwo
39827000 USD
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26358000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26572000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26980000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27256000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
117582 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
7004000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
90505 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4458000 USD
CY2017Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
50303000 USD
us-gaap Treasury Stock Reissued At Lower Than Repurchase Price
TreasuryStockReissuedAtLowerThanRepurchasePrice
5667000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
11808000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
84000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6910000 USD
expo Vested Restricted Stock Awards Issued To Settle Accrued Bonuses
VestedRestrictedStockAwardsIssuedToSettleAccruedBonuses
6334000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
135000 USD
us-gaap Revenues
Revenues
171962000 USD
us-gaap Revenues
Revenues
160451000 USD
CY2017Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1219000 USD
CY2016Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1901000 USD
CY2017Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1629000 USD
CY2016Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1524000 USD
CY2017Q2 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2016Q3 expo Entity Wide Sales Revenue Major Customer
EntityWideSalesRevenueMajorCustomer
0.1 pure
CY2017Q2 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
CY2017Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2532000 USD
CY2016Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3126000 USD
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000 shares
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2016Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
32853000 shares
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
7060000 shares
CY2016Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
7256000 shares
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
164587000 USD
us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
152284000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
7375000 USD
us-gaap Reimbursement Revenue
ReimbursementRevenue
8167000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
105954000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
99057000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
14466000 USD
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
14201000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
7375000 USD
us-gaap Cost Of Reimbursable Expense
CostOfReimbursableExpense
8167000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9216000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7659000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
34951000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
31367000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
500000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
310000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4307000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2734000 USD
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.95
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.42
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.36
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9391000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8608000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
39758000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
34411000 USD
us-gaap Operating Expenses
OperatingExpenses
137011000 USD
us-gaap Operating Expenses
OperatingExpenses
129084000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4807000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3044000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30961000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
25377000 USD
CY2016Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.18
CY2016 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.72
CY2016Q2 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4628000 USD
CY2016Q3 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4659000 USD
CY2016Q4 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
4607000 USD
CY2016 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
18569000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"></div> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><strong><font style="FONT-SIZE: 10pt">Use of Estimates.</font></strong> <font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Significant items subject to such estimates and assumptions include accounting for revenue recognition and estimating the allowance for contract losses and doubtful accounts. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016Q3 expo Entity Wide Account Receivable Major Customer Percentage
EntityWideAccountReceivableMajorCustomerPercentage
0.1 pure
expo Share Based Compensation Arrangements By Share Based Payment Award Options Expiration Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationTerm
P10Y

Files In Submission

Name View Source Status
0001144204-17-040607-index-headers.html Edgar Link pending
0001144204-17-040607-index.html Edgar Link pending
0001144204-17-040607.txt Edgar Link pending
0001144204-17-040607-xbrl.zip Edgar Link pending
expo-20170630.xml Edgar Link completed
expo-20170630.xsd Edgar Link pending
expo-20170630_cal.xml Edgar Link unprocessable
expo-20170630_def.xml Edgar Link unprocessable
expo-20170630_lab.xml Edgar Link unprocessable
expo-20170630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v471270_10q.htm Edgar Link pending
v471270_ex31-1.htm Edgar Link pending
v471270_ex31-2.htm Edgar Link pending
v471270_ex32-1.htm Edgar Link pending
v471270_ex32-2.htm Edgar Link pending